Puteaux, France November 9th, 2016 – ELITechGroup today announced a U.S. distribution agreement, with Abbott’s Molecular business, for molecular diagnostic reagents. The reagents target a range of genes associated with virus activity in patients that have undergone organ or hematopoietic stem cell transplantation. Additional products included within the agreement focus on sexually transmitted infections. It is anticipated that the ELITech products (ELITech ELITe MGB® Analyte Specific Reagents) will be available from Abbott in early 2017. “Based upon Abbott Molecular’s history and customer driven approach, we are confident that this partnership will increase access to the ELITechGroup molecular products.” commented Christoph Gauer, CEO of thehttp://www.elitechgroup.com/wp-content/uploads/2016/12/EMD-PR-ABBOTT-20161107.pdf ELITech Group. >> download the pdf“
Latest news
NEWSROOM
Let us help you
For general inquiries, please use the links to the right. The Contact link leads to a brief online form, and the Support link offers general phone and email information. Someone will be in touch with you soon.